{"title":"Design, synthesis, and high-throughput in vitro anti-cancer evaluation of novel 4-aminopyrazolo[3,4-d]pyrimidine derivatives: potential anti-cancer candidates against UO-31 renal cancer cells","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA05136J","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA05136J\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,30938-30953<br /><b>DOI</b>: 10.1039/D4RA05136J, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png\" alt=\"Creative Commons Licence\" /></a>Â  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\">Creative Commons Attribution 3.0 Unported Licence.</a></div><div>Amitananda Dash, Guruswamy Vaddamanu, Mohammed B. Hawsawi, Mustafa S. Alluhaibi, Pavana Kumari Gurijala, Naveen Mulakayala<br />Twenty novel 4-aminopyrazolo[3,4-<em>d</em>]pyrimidine core compounds were synthesized, characterized and identified as novel anti-cancer compounds. These compounds showed excellent activity against UO-31 Renal Cancer Cells.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"2ebf593b05f55b1a7de46ebacd5559006fc3405a96f2bcc6add4acb042db93ba","category":"Environment"}